MPG.eBooks - Description: Posaconazole for the treatment or prophylaxis of aspergillosis or candidiasis

Cover Image

Read Now

Posaconazole for the treatment or prophylaxis of aspergillosis or candidiasis a review of clinical effectiveness and guidelines

The purpose of this Rapid Response report is to review the clinical effectiveness and evidence-based guidelines regarding the use of posaconazole for the treatment or prophylaxis of aspergillosis or candidiasis

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, 27 May 2016
Series:	Rapid response report: summery with critical appraisal
Subjects:	Triazoles / Therapeutic Use Candidiasis / Drug Therapy Antifungal Agents / Therapeutic Use Aspergillosis / Drug Therapy Treatment Outcome Guidelines As Topic
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK368249
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The purpose of this Rapid Response report is to review the clinical effectiveness and evidence-based guidelines regarding the use of posaconazole for the treatment or prophylaxis of aspergillosis or candidiasis
Item Description:	"CADTH Rapid Response Service."
Physical Description:	1 PDF file (26 pages) illustration